Market Access Insights
Access the relevant market access data and insights you need on health plans, policy restrictions, PBMs, providers, and more
Formulary Advantages in Parkinson’s Disease Drugs: Impact of Generic Entry and Novel Formulation on Reimbursement
Parkinson's disease (PD) is one of the most common neurodegenerative diseases in the elderly. The launch of several new therapies and new formulations of key brands will drive market growth, but g…